BlackBerry to Host Investor Briefing at CES 2024
The session will discuss the key announcements for BlackBerry QNX and BlackBerry IVY® being showcased at the event.
BlackBerry Investor Briefing @ CES 2024
Presenters:
Mattias Eriksson, President, BlackBerry IoT
Tim Foote, VP, Investor Relations
Demonstrations of BlackBerry IoT's core products and how they position the business as the leader in foundational software for Automotive and the IoT Edge, will be available at the Consumer Electronics Show (CES) from
Register here for the webcast. A replay will be available on the BlackBerry.com/Investors website.
About BlackBerry
BlackBerry (NYSE: BB; TSX: BB) provides intelligent security software and services to enterprises and governments around the world. The company secures more than 500M endpoints including over 235M vehicles. Based in
BlackBerry. Intelligent Security. Everywhere.
For more information, visit BlackBerry.com and follow @BlackBerry.
Trademarks, including but not limited to BLACKBERRY and EMBLEM Design, are the trademarks or registered trademarks of BlackBerry Limited, and the exclusive rights to such trademarks are expressly reserved. All other trademarks are the property of their respective owners. BlackBerry is not responsible for any third-party products or services.
Investor Contact:
BlackBerry Investor Relations
+1 (519) 888-7465
[email protected]
Media Contact:
BlackBerry Media Relations
+1 (519) 597-7273
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/blackberry-to-host-investor-briefing-at-ces-2024-302014687.html
SOURCE BlackBerry Limited
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corgi Insurance Appoints McArn Bennett as Head of Public Policy and Corporate Affairs
- Snipp Interactive Reports Q2 2026 Financial Results; Returns to Positive EBITDA on Highest Quarterly Revenue in Five Quarters
- Akeso 2026 Interim Results: Strong Commercialization Momentum; IO2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
CESSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share